BTIG Keeps Price Targets on Oric Pharmaceuticals and Block Unchanged
BTIG kept its $26.00 price target on Oric Pharmaceuticals and its $100.00 target on Block, according to Dow Jones Newswires citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
BTIG maintained its price target of $26.00 per share on Oric Pharmaceuticals (ORIC) and its $100.00 per share target on Block (XYZ), according to Dow Jones Newswires. The ratings data was compiled from Benzinga.
Both notes were published on October 28, 2026, about ten minutes apart.
why it matters
A maintained target means the broker did not revise its valuation of the shares, so the notes carry little new information for the broader market. The main audience is investors who follow these two stocks.
tags
instruments
sources
- Oric Pharmaceuticals Price Target Maintained With a $26.00/Share by BTIG — Dow Jones Newswires, 28 October 2026 at 10:08 UTC
- Block Price Target Maintained With a $100.00/Share by BTIG — Dow Jones Newswires, 28 October 2026 at 10:18 UTC
- Robinhood Markets Price Target Maintained With a $135.00/Share by BTIG — Dow Jones Newswires, 28 October 2026 at 11:02 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗